Literature DB >> 8556501

Granulocyte colony-stimulating factor does not enhance phagocytosis or microbicidal activity of human mature polymorphonuclear neutrophils in vitro.

N Shimono1, K Okada, D Takeda, K Eguchi, H Misumi, Y Sawae, Y Niho.   

Abstract

The direct effects of human granulocyte colony-stimulating factor (hG-CSF) on mature polymorphonuclear neutrophils (PMNs) in vitro were studied with regard to chemotaxis, superoxide production, and phagocytosis and microbicidal activity against the following viable microorganisms: Staphylococcus aureus, serum-resistant Pseudomonas aeruginosa, and Candida albicans. Recombinant hG-CSF (rhG-CSF) acted as a chemoattractant for human PMNs in a dose-dependent manner. The chemotactic response of PMNs to N-formyl-methionyl-leucyl-phenylalanine (FMLP) was not enhanced by rhG-CSF at any of the concentrations used. rhG-CSF did not induce the generation of superoxide by itself. However, rhG-CSF was able to prime human PMNs and to enhance O2- release stimulated by FMLP in a dose-dependent manner. rhg-CSF did not enhance phagocytosis or killing of the three species of microorganisms by normal PMNs. With PMNs obtained from patients who had hematological disorders or solid tumors, no enhancement of the microbicidal activity was observed in most cases. Microbial killing mediated by PMNs depended on the ratio of PMNs to target organisms. We concluded from these facts that the most important effect of rhG-CSF was to increase the number of the peripheral PMNs and not to enhance the functions of mature PMNs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8556501      PMCID: PMC368338          DOI: 10.1128/cdli.1.5.556-562.1994

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  26 in total

1.  Therapeutic efficacy of granulocyte colony-stimulating factor alone and in combination with antibiotics against Pseudomonas aeruginosa infections in mice.

Authors:  H Yasuda; Y Ajiki; T Shimozato; M Kasahara; H Kawada; M Iwata; K Shimizu
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

2.  Therapy for neutropenia in hairy cell leukemia with recombinant human granulocyte colony-stimulating factor.

Authors:  J A Glaspy; G C Baldwin; P A Robertson; L Souza; M Vincent; J Ambersley; D W Golde
Journal:  Ann Intern Med       Date:  1988-11-15       Impact factor: 25.391

3.  Respiratory burst in adherent human neutrophils: triggering by colony-stimulating factors CSF-GM and CSF-G.

Authors:  C F Nathan
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

4.  Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial.

Authors:  R S Negrin; D H Haeuber; A Nagler; L C Olds; T Donlon; L M Souza; P L Greenberg
Journal:  Ann Intern Med       Date:  1989-06-15       Impact factor: 25.391

5.  Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor.

Authors:  G Morstyn; G J Lieschke; W Sheridan; J Layton; J Cebon; R M Fox
Journal:  Semin Hematol       Date:  1989-04       Impact factor: 3.851

6.  In vivo activation of human neutrophil functions by administration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma.

Authors:  A Ohsaka; S Kitagawa; S Sakamoto; Y Miura; N Takanashi; F Takaku; M Saito
Journal:  Blood       Date:  1989-12       Impact factor: 22.113

7.  Effect of recombinant human granulocyte colony-stimulating factor on human neutrophil adherence in vitro.

Authors:  Y Okada; M Kawagishi; M Kusaka
Journal:  Experientia       Date:  1990-10-15

8.  Direct action of human granulocyte colony-stimulating factor on mature human neutrophils: flow-cytometric analysis.

Authors:  S Kondo; S Okamura; N Ohhara; Y Niho
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1990-02

9.  Recombinant granulocyte colony-stimulating factor and lipopolysaccharide maintain the phenotype of and superoxide anion generation by neutrophils.

Authors:  Y Ichinose; N Hara; M Ohta; H Aso; H Chikama; M Kawasaki; I Kubota; T Shimizu; K Yagawa
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

10.  Recombinant human granulocyte colony-stimulating factor as an activator of human granulocytes: potentiation of responses triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence.

Authors:  A Yuo; S Kitagawa; A Ohsaka; M Ohta; K Miyazono; T Okabe; A Urabe; M Saito; F Takaku
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

View more
  1 in total

1.  Granulocyte colony-stimulating factor for the treatment of biomaterial-associated staphylococcal infections in-vitro.

Authors:  Andrea Schlöbe; Norbert Schnitzler; Klaus Schweizer; Detlef Rohde
Journal:  Urol Res       Date:  2002-12-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.